Evaluation of toxicological and antioxidant potential of Nardostachys jatamansi in reversing haloperidol-induced catalepsy in rats by Rasheed, A S et al.
© 2010 Rasheed et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of General Medicine 2010:3 127–136
International Journal of General Medicine
O R I G I N A L   R E S E A R C H
open access to scientific and medical research
Open Access Full Text Article
127
Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
9156
Evaluation of toxicological and antioxidant 
potential of Nardostachys jatamansi in reversing 
haloperidol-induced catalepsy in rats
A S Rasheed1 
S Venkataraman1 
K N Jayaveera2 
A Mohammed Fazil3 
K J Yasodha3 
M A Aleem3 
M Mohammed3 
Z Khaja3 
B Ushasri3 
H A Pradeep3 
M Ibrahim3
1Department of Pharmacology 
and Toxicology, C L Baid Metha 
College of Pharmacy, Jyothi Nagar, 
Thoraipakkam, Chennai, Tamil Nadu, 
India; 2Department of Chemistry, 
Jawaharlal Nehru Technology 
University, Anantapur, Andhra Pradesh, 
India; 3Nizam Institute of Pharmacy 
and Research Center, Deshmukhi, 
Pochampally (M), Near Ramoji Film 
City, Nalgonda, (AP), India
Correspondence: Mohammed Ibrahim
Nizam Institute of Pharmacy and 
Research Center, Deshmukhi, 
Pochampally (M), Near Ramoji Film City, 
Nalgonda, (AP), India
Tel +91 86 85 202 135
Fax +91 40 2324 0575
Email ibrahim_cce@rediffmail.com
Abstract: An aqueous root extract from Nardostachys jatamansi was investigated for its 
antioxidant and anticataleptic effects in the haloperidol-induced catalepsy rat model of the 
disease by measuring various behavioral and biochemical parameters. Catalepsy was induced 
by administration of haloperidol (1 mg/kg, ip) in male albino rats. A significant (P  0.01) 
reduction in the cataleptic scores were observed in all the drug-treated groups as compared to 
the haloperidol-treated group; with maximum reduction observed in the Nardostachys jatamansi 
(250 and 500 mg/kg body weight) administered group. To estimate biochemical parameters: 
the generation of thiobarbituric acid reactive substances (TBARS); reduced glutathione (GSH) 
content and glutathione-dependent enzymes; catalase; and superoxide dismutase (SOD), in the 
brain were assessed. Haloperidol administration increased generation of TBARS and signifi-
cantly reduced GSH, which were restored to near normal level with the Nardostachys jatamansi 
treatment. Catalase and SOD levels were also increased to normal levels, having been reduced 
significantly by haloperidol administration. Our findings of behavioral studies and biochemical 
estimations show that Nardostachys jatamansi reversed the haloperidol-induced catalepsy in 
rats. We conclude that the antioxidant potential has contributed to the reduction in the oxidative 
stress and catalepsy induced by haloperidol administration.
Keywords: Nardostachys jatamansi, antioxidant, toxicological, haloperidol and catalepsy
Introduction
The brain is deficient in oxidative defense mechanisms and hence is at a greater risk of 
damage mediated by reactive oxygen species (ROS), resulting in molecular and cellular 
dysfunction.1 ROS can damage virtually any biological molecule in its vicinity including; 
DNA, essential proteins, and membrane lipids.2 Parkinson’s disease is a neurodegenerative 
disease characterized by the selective loss of dopamine neurons of the substantia nigra 
pars compacta. The events, which trigger and/or mediate the loss of nigral dopamine 
neurons, remains unclear. Neuroleptic-induced catalepsy has long been used as an animal 
model for screening drugs for parkinsonism.3 Catalepsy is defined as the failure to cor-
rect an externally imposed posture. A condition characterized by inactivity, decreased 
responsiveness to stimuli, and a tendency to maintain an immobile posture. The limbs 
tend to remain in whatever position they are placed (waxy flexibility). Catalepsy may 
be associated with psychotic disorders (eg, schizophrenia, catatonia), nervous system 
drug toxicity, and other conditions. The catalepsy test is widely used to evaluate motor 
effects of drugs that act on the extrapyramidal system.4 Evidence suggests that immense 
oxidative stress, free radical formation,5 genetic susceptibility,6 and programmed cell 
death7 are the main causes for neurodegeneration associated with Parkinson’s and other International Journal of General Medicine 2010:3 128
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related diseases. The neuropathology of the disease is based on 
depigmentation and cell loss in the dopaminergic nigrostraital 
tract of the brain, with the corresponding decrease in the striatal 
dopamine (DA) concentration.8 Besides, dopamine receptor 
blockade and catecholamine depletion, other neurochemical 
hypotheses have been proposed for the development of cata-
lepsy such as striatonigral GABAergic (gamma-aminobutyric 
acid), cholinergic, glutamate, and serotonoergic.9–11 Haloperi-
dol is an antipsychotic drug which is used in the treatment of 
schizophrenia and other affective disorders. It blocks dopa-
minergic action in the nigrostraital pathway leading to a high 
frequency of extrapyramidal motor side effects.12 In animal 
models, haloperidol induces a behavioral state known as 
catalepsy in which the animals are unable to correct externally 
imposed postures.13 The use of haloperidol has been associ-
ated with an increased level of oxidative stress in the brain.14 
This evidence suggests a possible role for antioxidants in the 
treatment of haloperidol-induced catalepsy. The brain is made 
up of 70% lipid and any kind of stress is usually manifested by 
lipid peroxidative damage.15 The extent of this damage can be 
used to evaluate the degree of cellular harm. Stress-induced 
lipid peroxidative damage in the brain can be quantified by 
either determining the amount of peroxidative products or the 
rates of enzyme-catalyzed reactions neutralizing free radical 
intermediates such as superoxide dismutase (SOD). SOD is a 
primary, natural, and free radical scavenging and antioxidant 
enzyme in the body. The estimation of the activity of such 
antioxidant enzymes such as SOD, catalase, or glutathione 
peroxidase, can be used to assess the therapeutic effects of 
different antioxidant agents.16
Nardostachys jatamansi (    N. jatamansi) (    Valirenaceae) is 
indigenous to the Himalayan regions of India. In Ayurveda, 
roots and rhizomes of N. jatamansi are used to treat hysteria, 
epilepsy, and convulsions.17 The decoction of the drug is 
also used in neurological disorders, insomnia and disorders 
of cardiovascular system.18 The sesquiterpenes (Jatamansic 
acid, Jatamansone), lignans and neolignans are reported to be 
present in the roots of this plant.19,20 Rhizomes are reported 
to contain a terpenoid ester, Nardostachysin I.21 To date 
much research has been undertaken to evaluate the drug to 
treat various neurological and cardiovascular disorders in 
various animal models and is widely used in ayurvedic for-
mulations. It is reported to possess antidepressant activity,22 
anticonvulsant activity,23 antiarrhythmic activity,24 and pos-
sess antioxidant, and lipid peroxidation activity in doxoru-
bicin-induced cardiac damage in rats.25 It is also reported 
to improve learning and memory in mice26 and to enhance 
biogenic amine activity.27 An acetone extract of N. jatamansi 
has shown significant inhibition of benzoyl peroxide-induced 
cutaneous oxidative stress, toxicity, and ear edema in mice.28 
It has also been reported to possess protective activity in 
6-hydroxydopamine-induced, parkinsonism in rats.29 These 
pharmacological properties of N. jatamansi prompted us to 
evaluate its efficacy in haloperidol-induced parkinsonism.
Materials and methods
Plant material
Dried roots of N. jatamansi were purchased from a herbal 
market (Chennai, Tamil Nadu, India) and authenticated by 
Dr P Jayaraman, Director of the Plant Anatomy Research 
Centre, Chennai, India. A specimen voucher was deposited 
at the department of Pharmacology, C L Baid Metha College 
of Pharmacy, Chennai, India.
Preparation of aqueous extract  
of N. jatamansi
The dried roots were coarsely powdered and extracted with 
distilled water for 48 hours by cold maceration at room tem-
perature before being filtered. The filtrate was concentrated 
in rotary vacuum evaporator. Percentage yield was calculated 
with respect to the dried material and screened for its phyto-
constituents. The extract obtained was suspended in 1% v/v 
Tween 80 for oral administration.
HPTLC profile
Chromatography was performed on high performance thin 
layer chromatography (HPTLC) plates coated with 0.25 mm 
layer of silica gel 60 F254 (Merck, München, Germany). 
Before using, the plates were washed with methanol and acti-
vated at 110°C for 5 minutes Samples were applied as 4 mm 
wide bands and 6 mm apart by using a Linomat IV sample 
applicator (Camag Muttenz, Basel, Switzerland) equipped with 
100 µL syringe. A constant application rate of 5 µL/second was 
used. The mobile phase was petroleum ether-acetone (3:1v/v) 
and chromatograms were monitored at 254 nm (Figure 1).
Experimental animals
Inbred adult Wistar rats of either sex, weighing 150–200 gm 
were obtained from the animal house of the C L Baid Metha 
College of Pharmacy, India. The animals were maintained 
in a well-ventilated room with a 12-hour light/dark cycle in 
standard polypropylene cages under controled temperature 
(26 ± 1°C) and humidity (30%–40%). They were fed with 
a standard pellet diet obtained from Poultry Research Sta-
tion, Nandanam, Chennai, India. Water was supplied to the International Journal of General Medicine 2010:3 129
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animals ad libitum. Experimental protocols were approved 
by Institutional Animal Ethics Committee (IAEC) of 
C.P.C.S.E.A with ref no. IAEC/08/14/CLBMCP/2005–2006, 
dated 12– 20–2005.
Toxicity studies
Acute toxicity studies
Rats selected by a random sampling technique were used in 
the study. Acute oral toxicity was performed as per Organiza-
tion for Economic Co-operation and Development (OECD)-
423 guidelines.30 Three male Wistar rats weighing between 
150–200 g were used for each dose. The dose levels of 5 mg, 
50 mg, 500 mg, 1000 mg, 2000 mg, and 5000 mg/kg/body 
weight, per os were selected. The lethal dose (LD)-50 value of 
the extract was determined. The drug was administered orally 
to rats, which were fasted overnight with water ad libitum 
before the administration of the drug. The body weight of the 
rat was noted before and after treatment. The animals were 
observed for toxic symptoms, such behavioral changes, loco-
motion, convulsions, and mortality for 72 hours.
Repeated oral toxicity studies
In repeated oral toxicity studies drug extracts are adminis-
tered to the animal for a period covering approximately 10% 
of the expected life of the animal. Usually, the dose levels 
are lower than for acute studies and allow chemicals to accu-
mulate in the body before lethality occurs, if the chemical 
possesses this ability.31 Wistar rats of both sexes, 150–200 g 
Figure 1 HPTLC chromatogram of aqueous extract of N. jatamansi.
Abbreviation: HPTLC, high performance thin layer chromatography.
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were used for the study and kept in a temperature-controlled 
environment (26°C ± 1°C) with a 12-hour light/dark cycle. 
Food and water were freely available and were recorded 
each at 3-day intervals. The animals were divided into one 
control group and one treated group, each group consisting 
of six animals. The control group received Tween 80 and 
each treated group received the aqueous extract (1000 mg/kg 
body weight), by gavage once a day for 28 days. The animals 
were each weighed every 3 days. At the end of the experi-
ment, blood was collected from the orbital sinus, under ether 
anesthesia, for biochemical and hematological analysis. After 
the blood collection, the animals were sacrificed by cervical 
displacement and selected organs (brain, lungs, liver, heart, 
pancreas, kidney, and testis) were removed and collected in 
10% formalin solution in readiness for preparation of sec-
tions. The histopathological studies were carried following 
the method of Mukherjee.32
Experimental design
Adult male Wistar rats (180–250 g) were divided into six groups 
each containing six animals. Group I received the vehicle 1% 
Tween 80 solution and served as the control. Group II received 
haloperidol alone and served as the cataleptic control without 
any drug treatment. Group III received a combination of l-dopa 
and carbidopa (100 mg + 25 mg/kg by intraperitoneal admin-
istration) and served as positive control. Groups IV , V , and VI 
received N. jatamansi at a dose of 100, 250, 500 mg/kg body 
weight, respectively. Thirty minutes after the administration 
of these drugs, catalepsy was induced by the intraperitonial 
administration of haloperidol at a dose of 1 mg/kg body weight 
in normal saline. This procedure was repeated for 15 days. All 
the behavioral studies were performed at room temperature in 
a calm room without any external interference. The severity of 
catalepsy was measured every 30 minutes thereafter for a total 
duration for 3 hours. Catalepsy of an individual rat was measured 
in a stepwise manner using a scoring method described below. 
After 15 days of behavioral studies, animals were sacrificed by 
cervical dislocation and the whole brain was immediately dis-
sected out and washed in ice-cold saline to remove all traces of 
blood. The brains were weighed and a 10% tissue homogenate 
was prepared in 0.025 M Tris–HCl buffer at pH 7.5 and used to 
measure the activities of thiobarbituric acid reactive substances 
(TBARS). Enzyme activity was assayed in 10% brain homog-
enates prepared in 0.2 M phosphate buffer, pH 8.0.
Figure 2 HPTLC chromatogram of standard (Reference compound) Jatamansone.
Abbreviation: HPTLC, high performance thin layer chromatography.
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Behavioral studies
Measurement of catalepsy  
by block method33
This scoring method followed is in three steps. Step 1: The rat 
was taken out of the home cage and placed on a table. If the rat 
failed to move when touched or pushed gently on the back 
a score of 0.5 was assigned. Step II: The front paws of the 
rats were placed alternately on a 3-cm high block. If the rat 
failed to correct the posture within 15 seconds, a score of 0.5 
for each paw was added to the score of step 1. Step III: The 
front paws of the rat were placed alternately on a 9-cm high 
block, if the rat failed to correct the posture within 15 seconds 
a score of 1 for each paw was added to the scores of steps 
I and II. Thus, the highest score for any animal was 3.5 (cut 
off score) and that reflects total catalepsy (Table 3).
Behavioral assessment by metal bar test
Behavioral assessment in haloperidol-induced cataleptic 
rats was studied by the method of Kulkarni.34 Cataleptic 
behavior was measured with a high bar test method. Catalepsy 
score was measured for 4 hours at one-hour intervals after 
haloperidol administration by gently placing both forepaws 
of the rat over a metal bar (diameter 2–5 mm suspended 6 
cm above the table top). The intensity of catalepsy assessed 
by counting the time in seconds until the rat brought both 
forepaws down to the tabletop, with a maximum cutoff 
time of 3 minutes. Finally, scores at different time points 
(0, 60,120,180 and 240 minutes after haloperidol injection) 
were added and expressed as a cumulative catalepsy score 
for comparison purposes (Table 4).
Biochemical studies
Estimation of lipid peroxidation  
products
Lipid peroxidation was estimated colorimetrically in brain 
tissue by quantifying TBARS according to the method of 
Niehaus and Samuelson.35 In brief; for the estimation of 
TBARS the supernatant of the tissue homogenate was treated 
with tertiary butanol−trichloroacetic acid−hydrochloric acid, 
(TBA–TCA–HCl) reagent and mixed thoroughly. The mixture 
was kept in boiling water bath for 15 minutes. After cooling, 
the tubes were centrifuged for 10 minutes and the supernatant 
Table 2 Repeated oral toxicity studies
Groups Hb (gm %) RBC  
(millions/mm2)
WBC  
(per mm2)
Differential count
Neutrophils  
(%)
Lymphocytes  
(%)
Monocytes  
(%)
Eosinophils   
(%)
Control 14.62 ±  
0.06256 ns
5.297 ±  
0.16222 ns
7487 ±  
274.08 ns
50.33 ±  
1.406 ns
45.17 ±  
0.8333 ns
2.333 ±  
0.6148 ns
2.167 ±  
05426 ns
Test 14.63 ±  
0.08028 ns
5.075 ±  
0.1420 ns
7710 ±  
246.8 ns
52.17 ±  
1.167 ns
41.83 ±  
1.447 ns
2.667 ±  
0.6146 ns
3.500 ±  
0.6708 ns
Notes: Values are expressed in mean ± SEM. Each group consists of 6 rats. Statistical significance test for comparison was done by Student’s t-test.
Abbreviations: ns, not significant; Hb, hemoglobin; WBC, white blood corpuscles; RBC, red blood corpuscles.
Table 1 Acute toxicity study
Drug treatment Dose Average body weight of the animal in grams Signs of toxicity Effect observed Death
Before treatment  
(1st day)
After treatment  
(14th day)
Aqueous extract  
of N. jatamansi
5 mg/kg 169 175 No signs  
of toxicity
No effect Nil
Aqueous extract  
of N. jatamansi
50 mg/kg 160 169 No signs  
of toxicity
No effect Nil
Aqueous extract  
of N. jatamansi
500 mg/kg 167 174 No signs  
of toxicity
No effect Nil
Aqueous extract  
of N. jatamansi
1000 mg/kg 173 179 No signs  
of toxicity
No effect Nil
Aqueous extract  
of N. jatamansi
2000 mg/kg 155 164 No signs  
of toxicity
No effect Nil
Aqueous extract  
of N. jatamansi
5000 mg/kg  182  195  No signs  
of toxicity
No effect  Nil 
Notes: Body weight and signs of toxicity observed following treatment of aqueous extract of N. Jatamansi in rats for 14 days.International Journal of General Medicine 2010:3 132
Rasheed et al Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
taken for measurement. The developed color was read at 
535 nm using a UV spectrophotometer (Hitachi 912) against 
a reagent blank and expressed as mM per 100 g tissue.
Estimation of antioxidants
Catalase (CAT) was assayed colorimetrically at 620 nm and 
was expressed as micromoles of H2O2 consumed per minute 
per mg of protein; using the method described by Sinha.36 
The reaction mixture (1.5 mL, volume) contained 1.0 mL of 
0.01 M pH 7 phosphate buffer, 0.1 mL of tissue homogenate 
and 0.4 mL of 2 M H2O2. The reaction was stopped by the addi-
tion of 2 mL of dichromate-acetic acid reagent (5% potassium 
dichromate and glacial acetic acid mixed in the ratio of 1:3). 
The assay for SOD was based on SOD mediated inhibition 
of the reduction of nitroblue tetrazolium to blue formazan by 
superoxide anions as described by Beauchamp and Fridovich.37 
The total protein present in the homogenate was estimated 
following the method described by Lowry.38 Units of SOD 
activity determined were expressed in terms of milligrams of 
total protein (TP). Reduced glutathione (GSH) was determined 
by the method of Ellman.39 One mL of supernatant was treated 
with 0.5 mL of Ellman’s reagent and 3 mL of phosphate buf-
fer (0.2 M, pH 8.0). The absorbance was read at 412 nm. The 
activity of GSH was expressed as nM GSH formed/g tissue.
Statistical analysis
Each group of rats assigned to a specific drug treatment 
each group consisted of 6−9 animals. All the values are 
expressed as mean ± standard error of mean (SEM). The 
data were analyzed by analysis of variance (anova) followed 
by Tukey test. The criterion for statistical significance was 
P  0.05.
Results
The phytochemical analysis of an aqueous root extract of 
N. Jatamansi revealed the presence of sterols, carbohydrates, 
terpenes, phenols, gums and mucilage. The HPTLC finger-
print of the aqueous extract showed the presence of eight 
spots (Rf values 0.11, 0.23, 0.39, 0.44, 0.57, 0.66, 0.70 and 
0.84) (Figure 1) at a wavelength of 254 nm. The standard 
Table 3 Effect of aqueous extract of N. jatamansi on haloperidol-induced catalepsy by block method
Drug treatment 30 min 60 min 90 min 120 min 150 min 180 min
Tween 80 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Haloperidol 2.00 ± 0.224* 2.833 ± 0.211a** 3.5 ± 0.0a** 3.5 ± 0.0a** 3.167 ± 0.211a** 3.333 ± 0.167a**
N. jatamansi (100 mg) + 
haloperidol
1.85 ± 0.457* 2.792 ± 0.322* 2.612 ± 0.563* 2.356 ± 0.043b* 2.114 ± 0.63b* 1.923 ± 0.673b**
N. jatamansi (250 mg) + 
haloperidol
1.500 ± 0.342* 2.500 ± 0.259* 2.167 ± 0.211* 1.833 ± 0.211b** 1.417 ± 0.0833b** 1.02 ± 0.823b**
N. jatamansi (500 mg) + 
haloperidol
1.00 ± 0.213* 2.080 ± 0.326* 1.526 ± 0.243** 1.287 ± 0.0833b** 1.236 ± 0.056b** 0.5000 ± 0.224b**
l-dopa and carbidopa + 
haloperidol
0.5833 ± 0.833* 1.667 ± 0.117** 1.333 ± 0.105** 1.250 ± 0.112b** 1.13 ± 0.042b** 0.5 ± 0.0b**
Notes: Values are mean ± SEM (n = 6). Statistical analysis by one-way ANOVA, followed by Dunnett’s multiple comparison test.
*P  0.05, **P  0.01.
Abbreviations: SEM, standard error of mean; Min, minutes.
Table 4 Effect of aqueous extract of N. jatamansi on Haloperidol induced catalepsy by metal bar test
Drug treatment 0 min 60 min 120 min 180 min 240 min
Tween 20 8.500 ± 1.088 7.167 ± 1.138 5.167 ± 0.792 5.667 ± 0.558 5.667 ± 0.955
Haloperidol treated 5.833 ± 0.872 138.3 ± 3.333** 165 ± 3.651** 165.0 ± 5.625** 161.7 ± 5.270**
N. jatamansi (100 mg) + Haloperidol 6.832 ± 0.056 102 ± 2.348* 94.5 ± 4.387* 72.3 ± 2.567* 51.2 ± 3.246*
N. jatamansi (250 mg) + Haloperidol 8.167 ± 0.654 65.00 ± 4.830** 58.83 ± 3.468** 48.00 ± 3.109** 23.33 ± 2.472**
N. jatamansi (500 mg) + Haloperidol 5.643 ± 0.423 43.42 ± 3.147** 36.23 ± 4.123** 28.3 ± 2.148** 18.24 ± 0.185**
L-Dopa and carbidopa + Haloperidol 7.500 ± 0.8851 32.50 ± 3.354** 27.50 ± 2.141** 23.00 ± 1.826** 15.00 ± 1.826**
Notes: Values are mean ± SEM (n = 6). Statistical analysis by one-way ANOVA, followed by Dunnett’s multiple comparision test.
*P  0.05, **P  0.01.
Abbreviations: SEM, standard error of mean; Min, minutes.International Journal of General Medicine 2010:3 133
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reference compound, Jatamansone, had the Rf value of 0.39 
(Figure 2), hence it is confirmed that the aqueous extract 
contains terpenoids. The acute oral toxicity was undertaken 
according to the OECD guidelines 423 (acute toxicity class 
method). There was no considerable change in body weight 
either before or after experimental treatment and no signs 
of toxicity were observed (Table 1). The LD50 test of the 
aqueous extract was found to be greater than 5000 mg/kg 
body weight after oral administration. Repeated oral tox-
icity was carried out by administration of the extract at a 
dose of 1000 mg/kg body weight per os for 28 days. The 
extract treated rats did not show any significant changes in 
hematological parameters (hemoglobin red blood corpuscles 
[RBC], white blood corpuscles [WBC], neutrophils, mono-
cytes, eosinophils and lymphocytes) when compared with 
the normal control animals (Table 2). Histopathological 
examinations of the internal organs, ie, liver, kidney and 
brain, did not shown any changes in their normal architec-
ture, suggesting the safety of the drug (Figure 3) as the oral 
administration of the drug to normal rats had no significant 
effect. Based on these findings a dose of 100, 250, and 
500 mg/kg bodyweight were selected for the study. The 
cataleptic scores of the present study are given in Table 3 and 
4, assessed by block method and metal bar test, respectively. 
Haloperidol induced catalepsy significantly (P  0.01) at a 
dose of 1 mg/kg (intraperitoneal administration). Significant 
reversal in haloperidol-induced catalepsy was observed 
with the administration of N. jatamansi aqueous extract and 
combination of l-dopa and carbidopa. The maximal decrease 
(P  0.01) in catalepsy was observed in the group receiving 
aqueous extract of N. Jatamansi at a dose of 250 mg/kg. 
However, there was no pronounced reduction in the cataleptic 
scores at a dose of 500 mg/kg, but almost similar results were 
observed as observed at a dose of 250 mg/kg body weight.
The levels of lipid peroxidation products and antioxidants 
in the brains of haloperidol, drug-treated and control groups 
are shown in Table 5. The haloperidol-treated rats showed 
a significant increase (P  0.01) in TBARS and there was 
also a significant reduction (P  0.01) in SOD, CAT, and 
GSH in the brain tissue. Oral administration of the extract 
Figure 3 Histopathological slides of Brain (A control,   A1 test), Liver (B control, B1 test) and Kidney (C control, C1 test), Repeated oral toxicity study of Nardostachys jatamansi 
treatment for 28 days in rats showed no pathological changes.
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along with haloperidol administration significantly restored 
(P  0.01) the peroxides and antioxidant levels to near 
normal in the brains of the test animals. For all the param-
eters studied, N. jatamansi extract administered at doses of 
250 and 500 mg/kg bodyweight showed significant effects. 
l-dopa and carbidopa also showed a significant effect in all 
the parameters studied in rats.
Discussion
The central nervous system is especially vulnerable to 
free radical damage because of the brain’s high oxygen 
consumption, its abundant lipid content, and the relative 
paucity of antioxidant enzymes as compared with other 
tissues.40 Evidence also indicates that ROS may stimulate 
extracellular release of excitatory amino acids.41 Glutamate 
is the major excitatory amino acid in the brain which acts 
through various types of ionotropic receptors, the most 
significant being N-methyl D-aspartate (NMDA) receptors. 
There seems to be a bidirectional relationship between the 
ROS production and the release of excitatory aminoacids.42 
Free radicals generated in the brain are also reported to 
influence gene expression, subsequently effecting apopto-
sis and neuronal death.43 In the brain, an array of cellular 
defense systems exists to counterbalance the ROS. These 
include enzymatic and nonenzymatic antioxidants that 
lower the concentration of free radical species and repair 
oxidative cellular damage. The brain is known to synthe-
size molecules like glutathione and NADPH. Glutathione 
functions as a major antioxidant in tissue defense against 
free radicals in the brain. However, the concentration of 
glutathione is, relatively, in lesser quantities in the brain 
as compared to the other organs of the body.40 The natu-
ral antioxidant system present in brain can be in form of 
enzymes like catalase, peroxidase, superoxide dismutase 
or low molecular weight antioxidants (ascorbic and lipoic 
acids, carotenoids or indirectly acting chelating agents).43 
Free radical scavengers or antioxidants function as biologi-
cal bodyguards for essential molecules by either neutral-
izing reactive species before they mutilate a molecule or 
they repair damage that has been inflicted.
The present study demonstrates the antioxidant effects of 
an aqueous root extract of N. Jatamansi in haloperidol-induced, 
cataleptic oxidative stress in rats. The induction of free radi-
cals in mammals by haloperidol is well established. Previous 
studies have shown that dopamine receptors in the striatum are 
involved in neuroleptic-induced catalepsy. It has been demon-
strated that the cataleptic effects of haloperidol are apparently 
mediated by dopamine receptors localized postsynaptically 
on strial neurons.13 It is also well established that the admin-
istration of haloperidol leads to an increase in the oxidative 
stress in the brain tissue.14 The increase in SOD observed in 
the present study supports the this concept. Superoxide forma-
tion is a major factor in oxygen toxicity and the superoxide 
dismutase enzyme constitutes an essential defense against it. 
Under normal conditions, decreased activity of antioxidant 
enzymes, such as SOD, glutathione peroxidase and catalase, 
in the brain leads to the accumulation of oxidative free radi-
cals resulting in degenerative effects.44 An increase in these 
enzymes under normal conditions would represent increased 
antioxidant activity and a protective mechanism in neuronal 
tissue, thus, constituting the first line of defense against 
oxidative stress in our body. However, in the presence of a 
free radical-quenching agent, the induction of the antioxidant 
enzymes is minimized. So, any overall decrease in cataleptic 
scores and SOD activity in the drug treated groups indicates 
the ability of the drug extract to combat oxidative stress in 
brain tissue and reduce the severity of haloperidol-induced 
catalepsy. The altered balance of the antioxidant enzymes 
caused by the decrease in CAT, SOD, GSH activities may be 
responsible for the inadequacy of the antioxidant defenses in 
Table 5 Effect of N. jatamansi on TBARS, SOD, CAT, and GSH levels in normal and catalepsy-induced rat brain
Group TBARS (mM/100 g tissue) SOD (UA) Catalase (UB) GSH (mg/100 g tissue)
Control 1.13 ± 0.08 7.83 ± 0.70 2.99 ± 0.27 11.53 ± 0.50
Haloperidol treated 1.99 ± 0.12*** 4.58 ± 0.31*** 0.75 ± 0.05*** 5.82 ± 0.33***
l-dopa and carbidopa + Haloperidol 1.22 ± 0.05*** 6.42 ± 0.28*** 2.19 ± 0.22*** 9.15 ± 0.28***
N. jatamansi (100 mg) + Haloperidol 131 ± 0.43* 5.78 ± 0.45** 1.95 ± 0.20* 8.48 ± 0.51*
N. jatamansi (250 mg) + Haloperidol 1.15 ± 0.06*** 6.81 ± 0.50*** 2.49 ± 0.29** 9.98 ± 0.46***
N. jatamansi (500 mg) + Haloperidol 1.18 ± 0.21*** 6.89 ± 0.38*** 2.43 ± 0.23** 9.94 ± 0.38***
Notes: Values are mean ± SEM of six samples of six observations. Statistical significant test for comparison was done by ANOVA, followed Dunnett’s test.  AAmount of enzyme 
required to inhibit 50% of NBT reduction per mg protein. BMicromoles of H2O2 consumed per min per mg protein.
Abbreviations: SEM, standard error of mean; TBARS, thiobarbituric acid reactive substances; GSH, reduced glutathione; CAT, catalase; SOD, superoxide dismutase.International Journal of General Medicine 2010:3 135
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combating ROS mediated damage. The decreased activities 
of CAT and SOD may be a response to increased production 
of H2O2 and O2 by the autooxidation.45 It has been suggested 
that these enzymes play an important role in maintaining 
  physiological levels of oxygen and hydrogen peroxide by 
hastening the dismutation of oxygen radicals and eliminating 
organic peroxides and hydroperoxides. Treatment with N. 
jatamansi extract increased the activity of these enzymes 
by quenching the free radicals. Previously N. jatamansi 
has been reported to be a well known antioxidant and the 
ethanol extract of N. jatamansi is reported to possess potent 
antioxidant activity that scavenges free radicals generated 
after the induction of catalepsy.27 Significantly lower levels 
of lipid peroxides in the brains of the drug-treated group and 
increased activities of enzymatic and nonenzymatic antioxi-
dants in the brain suggests that the extract reduces oxidative 
stress. In previous studies N. jatamansi has been reported to 
have antilipid peroxidative and protective effect in rat cerebral 
ischemia.46,47 N. jatamansi has also been reported to enhance 
biogenic amine activity,48 decrease the level of dopamine and 
its metabolites and increasing the number of dopaminergic 
D2 receptors in striatum.29 Such evidence supports our study 
and indicates that the extract of N. jatamansi inhibits the 
symptoms of haloperidol-induced catalepsy in rats. The action 
by which the amelioration takes place may be attributed to 
one (or) more pharmacological/biochemical mechanisms. 
To conclude, the brain exhibits numerous morphological and 
functional alterations during oxidative stress, a factor impli-
cated in the pathogenesis of many CNS disorders. Treatment 
of such neuronal disorders with N. jatamansi plant extract 
significantly decreases lipid peroxidation and significantly 
increases the antioxidants in the brain. The findings of this 
study suggest the possible antioxidant role of N. jatamansi 
in overcoming behavioral and neurochemical changes during 
oxidative stress. Since the catalepsy test has predictive value 
regarding extrapyramidal effects, the possibility of pharma-
cological interactions between haloperidol and N. jatamansi 
extract should be further investigated in clinical studies.
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